| BRXCX | VTSNX | BRXCX / VTSNX | |
| Total Expense Ratio | 1.52 | 0.06 | 2,533% |
| Annual Report Gross Expense Ratio | 1.52 | 0.06 | 2,533% |
| Fund Existence | 10 years | 15 years | - |
| Gain YTD | 33.781 | 28.929 | 117% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.43B | 558B | 0% |
| Annual Yield % from dividends | 2.07 | 2.72 | 76% |
| Returns for 1 year | 33.05 | 28.01 | 118% |
| Returns for 3 years | 64.73 | 49.15 | 132% |
| Returns for 5 years | 51.80 | 32.65 | 159% |
| Returns for 10 years | 91.01 | 78.26 | 116% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SEVIX | 14.75 | N/A | N/A |
| SEI US Managed Volatility I (SIMT) | |||
| SCPIX | 54.76 | -0.02 | -0.04% |
| DWS S&P 500 Index S | |||
| JFNAX | 79.46 | -0.19 | -0.24% |
| Janus Henderson Global Life Sciences A | |||
| VSFSX | 25.51 | -0.07 | -0.27% |
| Federated Hermes MDT Small Cap Value R6 | |||
| PHPIX | 36.09 | -0.16 | -0.44% |
| ProFunds Pharmaceuticals UltraSector Inv | |||